AIIMS New Delhi, IIT Delhi, and University College London (UCL) have joined forces to drive advancements in medical technology. This strategic collaboration, announced on November 22, 2024, seeks to tackle global health challenges through joint research, innovation, and knowledge-sharing.
The partnership will focus on pioneering fields such as diagnostics, imaging, medical devices, artificial intelligence, and digital health.
Highlighting the initiative, Professor Alok Thakar, Head of the Centre for Medical Innovation and Entrepreneurship at AIIMS, stated, "By merging our expertise in medical science, engineering, and global policy, we aim to create a robust platform for MedTech innovation. This collaboration aspires to enhance patient care and redefine standards in medical technology."
Echoing this vision, Professor Rangan Banerjee, Director of IIT Delhi, underscored the need for accessible healthcare solutions. He remarked, "Through the synergy of science, engineering, and medicine, we can significantly transform lives. This partnership is set to deliver groundbreaking yet cost-effective medical technologies."
The partnership will include student and staff exchanges, joint research programmes, collaborative degrees, and knowledge-sharing through workshops and publications. Dr Michael Spence, UCL's President and Provost, said, "At UCL we recognise the difference that international collaboration can make to solving pressing global challenges and we know the power that bringing together different disciplines can have".
Â
As part of the MoU signing, the delegation visited mPRAGATI, IIT Delhi's medical technology development centre. Professor Naresh Bhatnagar, IIT Delhi's Dean of R&D, highlighted the collaboration's global impact: "Today's medical science relies heavily on technology. Together, we aim to benefit people not just in India and the UK but globally."
Comments
The partnership marks a significant step in strengthening ties between these institutions, comprising expertise in engineering, medicine, and global policy to drive innovation in healthcare.
Comentarios